HeimRGEDF • OTCMKTS
add
Gedeon Richter Ord Shs
Við síðustu lokun
27,17 $
Árabil
24,01 $ - 29,58 $
V/H-hlutf.
-
A/V-hlutfall
-
Viðskiptafréttir
Fjármál
Rekstrarreikningur
Tekjur
Nettótekjur
| (HUF) | sep. 2024info | Breyting á/á |
|---|---|---|
Tekjur | 216,73 ma. | 14,95% |
Rekstrarkostnaður | 94,69 ma. | 10,59% |
Nettótekjur | 37,06 ma. | -32,07% |
Hagnaðarhlutfall | 17,10 | -40,89% |
Hagnaður á hvern hlut | — | — |
EBITDA | 76,39 ma. | 23,89% |
Virkt skatthlutfall | 19,13% | — |
Efnahagsreikningur
Heildareignir
Heildarskuldir
| (HUF) | sep. 2024info | Breyting á/á |
|---|---|---|
Reiðufé og skammtímafjárfestingar | 74,99 ma. | -29,24% |
Heildareignir | 1,49 bn | 9,53% |
Heildarskuldir | 258,83 ma. | -1,37% |
Eigið fé alls | 1,23 bn | — |
Útistandandi hlutabréf | 182,62 m. | — |
Eiginfjárgengi | 0,00 | — |
Arðsemi eigna | 10,29% | — |
Ávöxtun eigin fjár | 11,59% | — |
Peningaflæði
Breyting á handbæru fé
| (HUF) | sep. 2024info | Breyting á/á |
|---|---|---|
Nettótekjur | 37,06 ma. | -32,07% |
Handbært fé frá rekstri | 67,55 ma. | 56,30% |
Reiðufé frá fjárfestingum | -13,69 ma. | 54,12% |
Reiðufé frá fjármögnun | -36,70 ma. | -409,23% |
Breyting á handbæru fé | 17,12 ma. | -34,71% |
Frjálst peningaflæði | 13,19 ma. | 1.594,12% |
Um
Gedeon Richter Plc. is a European multinational pharmaceutical and biotechnology company headquartered in Budapest. It is the largest pharmaceutical company in Central and Eastern Europe, with an expanding direct presence in Western Europe, China, Northern America and Latin America. Richter has the largest R&D unit in Central and Eastern Europe and operations in over 100 countries.
Gedeon Richter Plc. has a primary listing on the Budapest Stock Exchange and is a constituent of the BUX Index. It had a market capitalisation of approximately $6.6 billion as of 2018, the third largest of companies with a primary listing on the Budapest Stock Exchange. It has secondary listings on the Luxembourg Stock Exchange.
Richter sells products for the central nervous system, women's health and cardiovascular therapeutic areas among others. The company is also active in biosimilar product development. The company was established in Budapest by Gedeon Richter, a pharmacist, in 1901. Wikipedia
Framkvæmdastjóri
Stofnsett
1901
Vefsvæði
Starfsfólk
11.603
